Lifecore Biomedical, Inc. SC 13D/A
Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the common stock, par value $0.001 per share, of Lifecore Biomedical, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: January 11, 2024
| 22NW FUND, LP | |||
| By: | 22NW Fund GP, LLC General Partner | ||
| By: | /s/ Aron R. English | ||
| Name: | Aron R. English | ||
| Title: | Manager | ||
| 22NW, LP | |||
| By: | 22NW GP, Inc. General Partner | ||
| By: | /s/ Aron R. English | ||
| Name: | Aron R. English | ||
| Title: | President and Sole Shareholder | ||
| 22NW FUND GP, LLC | |||
| By: | /s/ Aron R. English | ||
| Name: | Aron R. English | ||
| Title: | Manager | ||
| 22NW GP, INC. | |||
| By: | /s/ Aron R. English | ||
| Name: | Aron R. English | ||
| Title: | President and Sole Shareholder | ||
/s/ Aron R. English | |
| ARON R. ENGLISH | |
/s/ Bryson O. Hirai-Hadley | |
| BRYSON O. HIRAI-HADLEY | |
| /s/ Nathaniel Calloway | |
| NATHANIEL CALLOWAY |
